A carregar...

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

PURPOSE: Outcomes after the treatment for unresectable or advanced-stage hepatocellular carcinoma (HCC) are unsatisfied. We evaluated the therapeutic benefits of a combination therapy strategy for these patients through transarterial chemoembolization (TACE) plus sorafenib. PATIENTS AND METHODS: In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Zou, Xinhua, Fan, Wenzhe, Xue, Miao, Li, Jiaping
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8142557/
https://ncbi.nlm.nih.gov/pubmed/34040442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S304591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!